Irina V Lebedeva Selected Research

Irina V Lebedeva Research Topics

Disease

32	Neoplasms (Cancer) 10/2017 - 02/2003
31	Melanoma (Melanoma, Malignant) 11/2010 - 01/2002
11	Infections 01/2023 - 01/2002
6	Pancreatic Neoplasms (Pancreatic Cancer) 09/2008 - 01/2005
4	Prostatic Neoplasms (Prostate Cancer) 04/2008 - 11/2003
4	Glioma (Gliomas) 02/2008 - 02/2003
4	Carcinoma (Carcinomatosis) 02/2007 - 11/2003
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2008 - 02/2007
2	Ovarian Neoplasms (Ovarian Cancer) 08/2006 - 08/2004
2	Glioblastoma (Glioblastoma Multiforme) 08/2003 - 07/2003
2	Necrosis 08/2003 - 07/2003
1	COVID-19 01/2023
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 10/2017
1	Colorectal Neoplasms (Colorectal Cancer) 11/2007
1	Neoplasm Metastasis (Metastasis) 02/2007
1	Lung Neoplasms (Lung Cancer) 02/2007
1	Carcinogenesis 01/2005
1	Inflammation (Inflammations) 10/2004
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2003
1	Renal Cell Carcinoma (Grawitz Tumor) 07/2003
1	Brain Neoplasms (Brain Tumor) 02/2003

Drug/Important Bio-Agent (IBA)

22	InterleukinsIBA 09/2008 - 08/2003
21	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2002
18	CytokinesIBA 11/2010 - 02/2003
7	Messenger RNA (mRNA)IBA 09/2008 - 01/2002
3	Monoclonal AntibodiesIBA 01/2023 - 11/2007
3	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2010 - 12/2003
3	ErbB Receptors (EGF Receptor)IBA 06/2008 - 08/2004
3	Interleukin-10 (Interleukin 10)IBA 06/2008 - 05/2004
3	Polyribonucleotide Nucleotidyltransferase (Polynucleotide Phosphorylase)IBA 05/2008 - 07/2003
3	mezereinIBA 09/2006 - 01/2002
3	Interferon-betaIBA 09/2006 - 01/2002
2	perillyl alcoholIBA 09/2008 - 07/2008
2	Amino Acids FDA Link 06/2008 - 08/2006
2	CaspasesIBA 04/2008 - 02/2008
2	Hormones (Hormone)IBA 04/2008 - 11/2003
2	p38 Mitogen-Activated Protein KinasesIBA 08/2006 - 07/2002
2	Arsenic Trioxide (Trisenox)FDA Link 01/2005 - 07/2003
2	Acetylcysteine (Siran)FDA LinkGeneric 10/2004 - 12/2003
2	DNA (Deoxyribonucleic Acid)IBA 08/2003 - 07/2003
2	Protein Kinase CIBA 10/2002 - 01/2002
1	EpitopesIBA 01/2023
1	AntibodiesIBA 01/2023
1	Protein Isoforms (Isoforms)IBA 10/2017
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 10/2017
1	CeramidesIBA 11/2010
1	Recombinant ProteinsIBA 06/2008
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 06/2008
1	Caspase 7IBA 04/2008
1	Caspase 3 (Caspase-3)IBA 04/2008
1	Caspase 8 (Caspase-8)IBA 04/2008
1	bardoxolone methylIBA 04/2008
1	bardoxoloneIBA 04/2008
1	1- (2- cyano- 3,12- dioxooleana- 1,9- dien- 28- oyl) imidazoleIBA 04/2008
1	TriterpenesIBA 04/2008
1	imidazoleIBA 04/2008
1	AcidsIBA 04/2008
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 04/2008
1	Caspase 10IBA 04/2008
1	Caspase 9IBA 04/2008
1	CathepsinsIBA 02/2008
1	Small Interfering RNA (siRNA)IBA 11/2007
1	Antineoplastic Agents (Antineoplastics)IBA 02/2007
1	Singlet OxygenIBA 02/2007
1	Gefitinib (Iressa)FDA Link 02/2007
1	Endoplasmic Reticulum Chaperone BiPIBA 08/2006
1	Phosphotransferases (Kinase)IBA 02/2006
1	retinamideIBA 01/2005
1	Complementary DNA (cDNA)IBA 01/2005
1	Chemokine CCL5IBA 10/2004
1	Interleukin-6 (Interleukin 6)IBA 10/2004
1	Interleukin-8 (Interleukin 8)IBA 10/2004
1	NF-kappa B (NF-kB)IBA 10/2004
1	NF-KappaB Inhibitor alphaIBA 10/2004
1	Matrix Metalloproteinases (MMPs)IBA 10/2004
1	RNA (Ribonucleic Acid)IBA 10/2004
1	Indicators and Reagents (Reagents)IBA 10/2004
1	AgarIBA 08/2004
1	AntioxidantsIBA 12/2003
1	1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium SaltIBA 12/2003
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2003
1	Bongkrekic AcidIBA 12/2003
1	thiazolyl blueIBA 08/2003
1	ExoribonucleasesIBA 07/2003
1	Free RadicalsIBA 07/2003
1	adenovirus receptorIBA 07/2003
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 04/2003
1	HSP27 Heat-Shock ProteinsIBA 07/2002
1	SB 203580IBA 07/2002
1	interleukin-24 (ST16)IBA 01/2002

Therapy/Procedure

23	Therapeutics 01/2023 - 01/2002
8	Drug Therapy (Chemotherapy) 03/2009 - 07/2003
4	Radiotherapy 03/2009 - 07/2003
2	Injections 05/2008 - 09/2006
1	Chemoprevention 07/2008
1	Molecular Targeted Therapy 02/2006
1	Aftercare (After-Treatment) 01/2002